Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats

Figure 3 Lipid markers measurements in the control group and other experimental groups. The data, presented as means ± SE (n = 6), indicate significant differences at P < 0.05. STZ: Streptozotocin; MET: Metformin; CHO: Cholecalciferol; TAU: Taurine; TGs: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; VLVL-C: Very low-density lipoprotein cholesterol. ^aSignificance compared to the control group. ^bSignificance compared to the Streptozotocin diabetic group. ^cSignificance compared to the metformin-treated group.